New weight-loss injection targets fat cells: CBL-514 selectively induces apoptosis of fat cells

Details of a caller injection that targets abdominous cells volition beryllium released astatine the yearly gathering of the European Association for the Study of Diabetes (EASD) successful Milan, Italy (Sept. 28–Oct. 2). Studies amusement that the caller drug, CBL-514, reduces levels of subcutaneous and visceral fat. The information besides suggest that it helps bounds value regain aft radical halt taking GLP-1 receptor agonist drugs (GLP1-RAs), says Dr. W. Timothy Garvey of the University of Alabama astatine Birmingham.